|
業務類別
|
Biotechnology |
|
業務概覽
|
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation.It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors. |
| 公司地址
| 830 Winter Street, Waltham, MA, USA, 02451 |
| 電話號碼
| +1 857 399-9500 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.tscan.com |
| 員工數量
| 195 |
| Dr. Chrystal U. Louis, M.D.,M.P.H. |
Chief Medical Officer |
美元 343.13K |
14/05/2025 |
| Dr. Zoran Zdraveski, J.D.,PhD |
Secretary, Chief Legal and Strategy Officer |
-- |
14/05/2025 |
| Dr. Gavin MacBeath, PhD |
Chief Executive Officer and Director |
美元 620.00K |
04/03/2026 |
| Mr. Leiden Dworak |
Principal Accounting Officer and Vice President, Finance |
-- |
04/03/2026 |
| Mr. Jason A. Amello |
Treasurer and Chief Financial Officer |
美元 463.54K |
04/03/2026 |
|
|
| Mr. Garry A. Nicholson |
Independent Director |
04/03/2026 |
| Dr. Gabriela Gruia, M.D. |
Independent Director |
04/03/2026 |
| Ms. Katina Dorton, J.D.,M.B.A. |
Independent Director |
04/03/2026 |
| Dr. Gavin MacBeath, PhD |
Chief Executive Officer and Director |
04/03/2026 |
| Mr. Robert Keith Woods |
Independent Director |
04/03/2026 |
| Dr. Stephen R. Biggar,M.D.,PhD |
Chairman of the Board |
04/03/2026 |
| Dr. Barbara Klencke, M.D. |
Independent Director |
04/03/2026 |
|
|
|
|
